Barclays PLC
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BCLYF | HSBC | SAN | CM | BNY | BNS | |
|---|---|---|---|---|---|---|
| Market cap | 77.32B | 319.05B | 189.54B | 101.77B | 96.78B | 111.17B |
| P/E (TTM) | 8.9 | 13.3 | 12.7 | 14.9 | 15.8 | 16.5 |
| Forward P/E | — | 9.8 | 9.2 | 14.0 | 13.7 | 13.6 |
| Price/book | 0.9 | 7.4 | 1.5 | 2.2 | 2.4 | 1.8 |
| Dividend yield | 2.65% | 3.97% | 2.09% | 2.68% | 1.55% | 3.51% |
| 1-year change | +13.73% | +44.01% | +34.75% | +39.31% | +32.07% | +42.99% |
| Today | +1.22% | −1.35% | −1.43% | −0.35% | −0.46% | −0.43% |
The closest companies by business and industry (Banks - Diversified). Prices may be delayed up to 15 min.
Latest news
All BCLYF news ›Fastenal Company (FAST) Gets a Hold from Barclays
Barclays analyst Guy Hardwick maintained a Hold rating on Fastenal Company today and set a price target of $46.00. According to TipRanks, Hardwick is a 5-star analyst with an average return of 16.5% and a 72.22% success rate. Hardwick…
Barclays Remains a Hold on HCA Healthcare (HCA)
In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on HCA Healthcare, with a price target of $387.00. Mok CFA covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Addus…
Barclays Remains a Buy on Marsh & McLennan Companies (MRSH)
Barclays analyst Alex Scott maintained a Buy rating on Marsh & McLennan Companies today and set a price target of $206.00. According to TipRanks, Scott is a 5-star analyst with an average return of 8.1% and a 60.31% success rate. Scott…
Barclays Keeps Their Buy Rating on Datadog (DDOG)
Barclays analyst Raimo Lenschow maintained a Buy rating on Datadog today and set a price target of $300.00. Lenschow covers the Technology sector, focusing on stocks such as Salesforce, HubSpot, and Atlassian. According to TipRanks,…
Collegium Pharmaceutical (COLL) Receives a Buy from Barclays
Barclays analyst Jenna Davidner maintained a Buy rating on Collegium Pharmaceutical today and set a price target of $48.00. Davidner covers the Healthcare sector, focusing on stocks such as Collegium Pharmaceutical, Xeris Pharmaceuticals,…
Barclays Keeps Their Buy Rating on Fervo Energy Company Class A (FRVO)
Barclays analyst David Anderson maintained a Buy rating on Fervo Energy Company Class A today and set a price target of $48.00. According to TipRanks, Anderson is a 4-star analyst with an average return of 7.3% and a 51.30% success rate.…
Datadog price target raised to $300 from $290 at Barclays
Barclays raised the firm’s price target on Datadog (DDOG) to $300 from $290 and keeps an Overweight rating on the shares. The firm adjusted targ... Datadog price target raised to $300 from $290 at Barclays Barclays raised the firm’s price…
Cummins (CMI) PT Lowered to $675 at Barclays
Barclays analyst Adam Seiden lowered the price target on Cummins (NYSE: CMI) to $675.00 (from $760.00) while maintaining a Overweight rating. StreetInsider.com Top Tickers, 10/19/2026 - Wall Street tumbles as worries about AI trade and…
Barclays shares have just fallen 9%, but experts say they’re heading to 580p!
James Beard thinks the recent drop in Barclays’ shares could be an excellent buying opportunity to consider. But it may pay to wait a little longer. Since the middle of September, Barclays‘ (LSE:BARC) shares have fallen nearly 10% (18…
Barclays Keeps Their Buy Rating on Hyatt Hotels (H)
In a report released today, Brandt Montour from Barclays maintained a Buy rating on Hyatt Hotels, with a price target of $202.00. Montour covers the Consumer Cyclical sector, focusing on stocks such as Viking Holdings, Boyd Gaming, and…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com149
-
gurufocus.com80
-
marketbeat.com74
-
tradingview.com68
-
theglobeandmail.com47
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.